Diet in infancy and later signs of beta-cell autoimmunity.
- 3 March 2011
- journal article
- letter
- Published by Massachusetts Medical Society in New England Journal of Medicine
- Vol. 364 (9) , 879-880
Abstract
The analysis by Knip et al (Nov. 11 issue),1 which suggests that dietary intervention through infant weaning to hydrolyzed formula has a long-lasting effect on markers of beta-cell autoimmunity, is flawed in that it has overestimated the evidence of benefit because of failure to adequately use the intention-to-treat principle.2 First, children from whom follow-up samples were not obtained were excluded from the primary analysis of seroconversion to autoantibody positivity. Of the children who were excluded, diabetes (and presumably autoantibody positivity before clinical disease) developed in three in the treatment group versus none in the control group. Correct inclusion of these 3 children in an intention-to-treat protocol would minimize evidence of treatment effect, with the development of beta-cell autoimmunity in 11 of 113 infants randomly assigned to hydrolyzed formula (9.7%) and in 17 of 109 infants assigned to standard formula (15.6%). A second breach of the principle occurred by adjusting for the duration of exposure to the study formula. In so doing, the authors were able to invalidly “improve” the P value regarding the hazard of development of two or more markers of beta-cell autoimmunity between treatment groups from 0.12 to 0.07.Keywords
This publication has 5 references indexed in Scilit:
- Dietary Intervention in Infancy and Later Signs of Beta-Cell AutoimmunityNew England Journal of Medicine, 2010
- Dynamics of Diabetes-Associated Autoantibodies in Young Children with Human Leukocyte Antigen-Conferred Risk of Type 1 Diabetes Recruited from the General PopulationThe Journal of Clinical Endocrinology & Metabolism, 2005
- Natural course of preclinical type 1 diabetes in siblings of affected childrenActa Paediatrica, 2003
- Post-randomisation exclusions: the intention to treat principle and excluding patients from analysisBMJ, 2002
- Transient Antiislet Autoantibodies: Infrequent Occurrence and Lack of Association with "Genetic" Risk FactorsThe Journal of Clinical Endocrinology & Metabolism, 2000